Ping-Pong-Tumor and Host in Pancreatic Cancer Progression

Area of Science:

• Oncology
• Cancer Metastasis Research
• Cellular Biology

Background:

• Pancreatic cancer (PaCa) exhibits high mortality rates, largely due to metastasis, with current treatments showing limited efficacy.
• Tumor progression in PaCa is a complex process involving crosstalk between cancer-initiating cells (CIC), surrounding tissues, and distant organs, significantly mediated by tumor-derived extracellular vesicles (TEX).
• Key hallmarks of PaCa progression include prominent stroma reaction, recruitment of immunosuppressive leukocytes, perineural invasion, and early dissemination to the liver and lungs.

Purpose of the Study:

• To review the current knowledge on pancreatic cancer-initiating cell (PaCIC) markers involved in the metastatic cascade.
• To explore the role of PaCIC markers in tumor-derived extracellular vesicle (TEX) biogenesis, targeting, and uptake.
• To discuss PaCa-specific features, including feedback loops between stromal elements and tumor cells, and the influence of the tumor microenvironment on disease aggressiveness.

Main Methods:

• Literature review and synthesis of existing research on pancreatic cancer metastasis.
• Analysis of the roles of specific PaCIC markers (e.g., Tspan8, CD44v6, CXCR4) in metastasis.
• Discussion of the contribution of pancreatic stellate cells (PSC), immune cells, and nerve interactions to PaCa progression.

Main Results:

• Identified several PaCIC markers (Tspan8, alpha6beta4, CD44v6, CXCR4, LRP5/6, LRG5, claudin7, EpCAM, CD133) implicated in the metastatic cascade, often through PaCIC-TEX.
• Highlighted the critical role of pancreatic stellate cells (PSC) in facilitating PaCa adaptation to hypoxia via metabolic shifts and nutrient transfer, and their contribution to perineural invasion.
• Described the immunosuppressive tumor microenvironment in PaCa, characterized by the dominance of immunosuppressive cells and factors that hinder anti-tumor immune responses.

Conclusions:

• Deciphering the molecular mechanisms underlying PaCa metastasis, including PaCIC-TEX interactions and the tumor microenvironment, is crucial for developing effective therapies.
• Targeting PaCIC markers and their associated pathways, as well as modulating the immunosuppressive tumor microenvironment, holds promise for improving treatment outcomes.
• Further research into these complex interplays may transform lethal pancreatic cancer into a curatively treatable disease.